alpha-L-Fuc-(1->2)-alpha-D-Gal-(1->3)-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-ceramide(d18:1(4E))

Term ID

CHEBI:141099

Synonyms

alpha-L-Fuc-(1->2)-iGb3Cer(d18:1(4E))
alpha-L-fucosyl-(1->2)-alpha-D-galactosyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:1(4E))
alpha-L-fucosyl-(1->2)-alpha-D-galactosyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-N-acyl-sphing-4E-enine
iso-Fuc-Gb3-Cer(d18:1(4E))
isogloboside Fuc-iGb3Cer (d18:1(4E))

Definition

References

Ontology

ChEBI ( EBI )

Relationships

is a type of: organic molecular entity

organic molecular entity Show first 5 Terms
has_functional_parent: alpha-D-Galp-(1->3)-beta-D-Galp-(1->4)-beta-D-Glcp-(1<->1')-Cer

alpha-D-Galp-(1->3)-beta-D-Galp-(1->4)-beta-D-Glcp-(1<->1')-Cer Show first 5 Terms

Phenotype

Phenotype resulting from alpha-L-Fuc-(1->2)-alpha-D-Gal-(1->3)-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-ceramide(d18:1(4E))

Phenotype where environments contain alpha-L-Fuc-(1->2)-alpha-D-Gal-(1->3)-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-ceramide(d18:1(4E))

Phenotype modified by environments containing alpha-L-Fuc-(1->2)-alpha-D-Gal-(1->3)-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-ceramide(d18:1(4E))

Human Disease Model